4Bachmann KA,Sullivan TJ.Dispositional and pharmacodynamiccharacteristics of brodifacoum in warfarin-sensitive rats[J].Pharmacology,1983,27(6):281-289.
5Andre C,Guyon C,Thomassin M,et al.Association mechanismbetween a series of rodenticide and humic acid:a front alanalysisto support the biological data[J].J Chromatogr B Analyt TechnolBiomed Life Sci,2005,820(1):9-14.
6Weitzel JN,Sadowski JA,Furie BC,et al.Surreptitious ingestion of along-acting vitamin K antagonist/rodenticide,brodifacoum:clinical andmetabolic studies of hree cases[J].Blood,1990,76(12):2555-2559.
7Sarin S,Mukhtar H,Mirza MA.Prolonged coagulopathy related tosuperwarfarin overdose[J].Ann Intern Med,2005,142(2):156.
8Wasley LC, Rehemtulla A, Bristol FA, et al. PACE/furin canproc- ess the vitamin K-dependent pro-factor IX precursor within the secre- tory pat hway[J]. J Biol Chem, 1993,268(8) :8458-8459.
9Weitzel JN, Sadowski JA, Furie BC, et al. Surreptitious ingestion of a long -acting vitamin K antagonist/rodenticide, brodifacoum: clini- cal and metabolic studies of three cases[J]. Blood, 1990,76(12) : 2555-2559.
10Sarin S, Mukhtar H, Mirza MA. Prolonged coagulopathy related to superwarfarin overdose [ J ]. Ann Intern Med, 2005,142 (2) : 156- 157.
